12-01-2017 дата публикации
Номер: US20170006897A1
Автор:
Zihua Ao,
Carol Lynn Berseth,
Patricia Cobb,
Juan M. Gonzalez,
Johanna Kahn,
Bryan Yanwen Liu,
Elisha London,
Minhthy Nguyen,
James David Richards,
Colin Rudolph,
AO ZIHUA,
BERSETH CAROL LYNN,
COBB PATRICIA,
GONZALEZ JUAN M,
KAHN JOHANNA,
LIU BRYAN YANWEN,
LONDON ELISHA,
NGUYEN MINHTHY,
RICHARDS JAMES DAVID,
RUDOLPH COLIN,
Ao Zihua,
Berseth Carol Lynn,
Cobb Patricia,
Gonzalez Juan M.,
Kahn Johanna,
Liu Bryan Yanwen,
London Elisha,
Nguyen Minhthy,
Richards James David,
Rudolph Colin
Принадлежит:
A method for enhancing cognitive development in a pediatric subject involving administering to the subject a nutritional composition which includes up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein or protein equivalent source; 0.06 g/100 Kcal to 1.5 g/100 Kcal of an enriched milk product; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acid; and 0.015 g/100 Kcal to 1.5 g/100 Kcal of a prebiotic. 1. A method for enhancing cognitive development in a pediatric subject , the method comprising administering to the subject a nutritional composition comprising: up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein or protein equivalent source; 0.06 g/100 Kcal to 1.5 g/100 Kcal of enriched milk product; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acid; and 0.015 g/100 Kcal to 1.5 g/100 Kcal of a prebiotic , wherein the enriched milk product is present at a level such that the nutritional composition comprises 6 mg/100 Kcal to 300 mg/100 Kcal of phospholipids , 1 mg/100 Kcal to 30 mg/100 Kcal of sphingomyelin , and 0.25 mg/100 Kcal to 6 mg/100 Kcal of gangliosides.2. The method of claim 1 , wherein the enriched milk product is present at a level of 0.3 g/100 Kcal to 1.4 g/100 Kcal.3. (canceled)4. The method of claim 3 , wherein the enriched milk product comprises an enriched whey protein concentrate.5. The method of claim 1 , wherein the nutritional composition further comprises lactoferrin at a level of 5 mg/100 Kcal to 300 mg/100 Kcal.6. The method of claim 5 , wherein the lactoferrin is lactoferrin from a non-human source.7. The method of claim 5 , wherein the lactoferrin has at least 48% homology with human lactoferrin.8. The method of claim 1 , wherein the source of long chain polyunsaturated fatty acids includes at least one of docosahexaenoic acid claim 1 , arachidonic acid claim 1 , and combinations thereof.9. The method of claim 8 , wherein the source of long ...
Подробнее